Loading
SoftOx Solutions AS Stock: price and insider trades · Norway
SoftOx Solutions AS: what insiders have been doing
Every trade that managers of SoftOx Solutions AS disclose to Oslo Børs is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for SoftOx Solutions AS. The previous disclosure was published on 26 August 2025.
For comparison within the same sector, see the insider buying recorded at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.
Insider Decl.
13
Thresholds
n/a
Buy Volume
n/a
6 ops. · all time
Sell Volume
n/a
1 ops. · all time
Fundamental score
Ranked 23,281 of 24,158 companies
13.6
score / 100
Value22
Quality5
FCF yld-6.0%
Earn yld-3.4%
EV/EBITDA·
ROE-34%
Gross mgn·
Net mgn-69%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NOK 0.09
Analyst consensus
Income statement
RevenueNOK 15.6M
EBITDA-NOK 8.2M-52% margin
Net income-NOK 10.8M-109.8% margin
Valuation
P/Book9.1x
Beta0.99
Balance sheet & cash
Market capNOK 241.5M
Total debtNOK 10.2M
Free Cash Flow-NOK 18.9M
Profitability & ownership
ROE-27.8%
ROA-14.3%
% insiders54.8%
% institutions3.1%
Last declaration on 26 August 2025
Declarations13 total
ShareMERKOSLO:653885
ShareMERKOSLO:550460
ShareMERKOSLO:526811
ShareMERKOSLO:526232
ShareMERKOSLO:525927
1,000 shares@ NOK 30.00100.0% of flowOptionMERKOSLO:523676
ShareMERKOSLO:521993
ShareMERKOSLO:521992
13 of 13 declarations
About SoftOx Solutions AS
SoftOx Solutions AS is a Norwegian company focused on developing solutions for health and pharmaceuticals. It specializes in innovative treatments for infections and public health-related diseases.
